EXCLUSIVE LICENSE AGREEMENT between EAGLE PHARMACEUTICALS, INC. and CEPHALON, INC. dated February 13, 2015Exclusive License Agreement • May 15th, 2015 • Eagle Pharmaceuticals, Inc. • Pharmaceutical preparations • New York
This Exclusive License Agreement (this “Agreement”) is entered into as of February 13, 2015 (the “Effective Date”) by and between Eagle Pharmaceuticals, Inc., a Delaware corporation (“Eagle”) and Cephalon, Inc., a Delaware corporation (“Cephalon”). Eagle and Cephalon are sometimes referred to herein, individually, as a “Party” or, collectively, as “Parties.”
SETTLEMENT AND LICENSE AGREEMENTSettlement and License Agreement • May 15th, 2015 • Eagle Pharmaceuticals, Inc. • Pharmaceutical preparations • Delaware
This SETTLEMENT AND LICENSE AGREEMENT (this “Agreement”) is hereby entered into and made effective on February 13, 2015 (the “Effective Date”) by and between Cephalon, Inc. (“Cephalon”) and Eagle Pharmaceuticals, Inc. (“Eagle”). Cephalon and Eagle are referred to herein individually as a “Party” and collectively, as the “Parties.”
